Pasi A. Jänne, MD, PhD, MMSc

Pasi A. Jänne, MD, PhD, MMSc

Dana-Farber Cancer Institute

Research Interests

Translational research in thoracic malignancies focused on preclinical and
clinical approaches to treat and/or prevent drug resistance to genotype directed therapies.

Current Affiliations

Director, Chen-Huang Center for EGFR Mutant Lung Cancers; Director, Division of Thoracic and Head and Neck Oncology; Director, Lowe Center for Thoracic Oncology; Director, Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute; Coleader, Lung Cancer Program, Dana-Farber/Harvard Cancer Center; Professor, Medicine, Dana-Farber Cancer Institute and Harvard Medical School; Member, Biology and Biomedical Science (BBS) Graduate Program, Harvard Medical School; Associate Physician, Medicine, Brigham and Women’s Hospital, Boston, Massachusetts.

Previous Positions

Co-Scientific Director, Belfer Center for Applied Cancer Science (2011-2017); Director, Translational Research Laboratory (2009-2012), Dana-Farber Cancer Institute; Associate Professor (2008-2014), Assistant Professor (2004-2008), and Instructor (2001-2004), Medicine, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.

Postdoctoral Training

Fellow, Medical Oncology, Dana-Farber Cancer Institute (1998-2001); Clinical Fellow, Medicine, Brigham and Women’s Hospital and Harvard Medical School (1996-2001); Junior Assistant Resident, Internal Medicine (1997-1998) and Intern, Medicine (1996-1997), Brigham and Women’s Hospital, Boston, Massachusetts.

Selected AACR Service, Honors, and Awards

Recipient, AACR-Waun Ki Hong Award for Outstanding Achievement in Translational and Clinical Cancer Research (2018); Senior Editor (2017-2019) and Editorial Board Member (2009-2016), Clinical Cancer Research; Cochair, Annual Meeting Program Committee (2017-2018); Cochair; FDA-AACR Joint Workshop, “Liquid Biopsies in Oncology Drug and Device Development” (2017, 2016); Member, Publications Committee (2016-2019, 2011-2014); Member, Science Policy and Government Affairs Committee (2016-2017); Cochair, EACR-AACR-SIC Special Conference on Drug Resistance, Florence, Italy (2015); Cochair, AACR-IASLC Joint Conference on The Molecular Origins of Lung Cancer (2014); Cochair, AACR Translational Cancer Research for Basic Scientists Workshop (2012-2019); Member, Annual Meeting Clinical Trials Committee (2012-2014); Cochair, Special Conference, “Molecularly Targeted Therapies: Mechanisms of Resistance” (2012); Chair, Landon-AACR INNOVATOR Award for Research in Personalized Cancer Medicine Scientific Review (2012-2014); Recipient, AACR Richard and Hinda Rosenthal Memorial Award (2010); Recipient, AACR Team Science Award (2010).

Selected Non-AACR Service, Honors, and Awards

Recipient, R35 Outstanding Investigator Award, National Cancer Institute (2018); Recipient, Translational Research Award, European Society for Medical Oncology (2018); Recipient, American Cancer Society Clinical Research Professorship (2017-present); Elected Member, Finnish Academy of Science and Letters (2016); Elected Member, American Association of Physicians (2016); Member, Board of Directors, International Association for the Study of Lung Cancer (2013-2017); Chair, Programming Committee, Chicago Multidisciplinary Symposium in Thoracic Oncology, American Society of Clinical Oncology (2012); Vice Chair, Correlative Services, Respiratory Committee, Alliance for Clinical Trials in Oncology (2011-2015); Recipient, A Breath Away from The Cure Award, Bonnie J. Addario Lung Cancer Foundation (2010); Member, Board of Directors and Chair, Scientific Executive Committee, National Lung Cancer Partnership (2009-2013); Recipient, American Lung Association Award for Lung Cancer Research (2008); Elected Member, American Society of Clinical Investigation (2008).


MMSc, Clinical Investigation, Harvard University, Cambridge, Massachusetts (2002); MD and PhD, Genetics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania (1996); BA, Chemistry, Vassar College, Poughkeepsie, New York (1989).